NEW YORK (GenomeWeb) – Editas Medicine said today that it has priced its previously announced public offering of 4 million shares of common stock at $22.50 per share, giving the transaction a value of $90 million before expenses.
Registering provides access to this and other free content.
Already have an account?Login Now.
New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.
Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.
La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.
In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.